Revvity Signals || Signals One™

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Sustainable Pharma Manufacturing: Eco-Friendly Practices for the Pharmaceutical Industry

    The pharmaceutical business is of significant importance to the healthcare sector all over the world yet it is also among the manufacturing industries that are resourceconsuming Energyintensive production processes complicated chemical synthesis and mass packaging processes have all contributed to pollution and emissions of carbon emissions to the environment as part of the traditional drug manufa...

    What Are the Benefits of Implementing a Modern MES in Pharma?

    The pharmaceutical sector is rapidly changing in a bid to match the increasing pressure of regulation attain perfection in product quality and hasten the timetomarket A Pharma MES or Manufacturing Execution System is one of the most strategic investments that are strategically placed in this environment in terms of operational excellence

    Data Security Challenges in Pharma IT: Safeguarding Sensitive Information

    The pharmaceutical industry faces several data security challenges in its IT infrastructure primarily related to safeguarding sensitive information The nature of the data regulatory requirements and the increasing sophistication of cyber threats

    Trapicolast Emerges as a First-In-Class Response to Drug Resistance: The Weakest

    Malaria remains one of the worlds most persistent infectious diseases Each year it infects hundreds of millions and causes more than half a million deaths with subSaharan Africa bearing the overwhelming burden Children under five account for most fatalities highlighting malarias deep inequity

    Chiral Biosensors: Precision Tools for Safer Drugs

    The pharmaceutical industry has long been recognised the profound implications of chirality in drug design and development Enantiomers mirrorimage isomers of a chiral molecule show dramatically distinct pharmacokinetic PK and pharmacodynamic PD profiles One may be therapeutically active while its counterpart could be inactive or harmful As a result the precise detection discrimination and quantifi...

    7 B2B Pharma Display Ad Strategies That Actually Drive Leads (2026 Guide)

    Theres a quiet frustration most pharma marketers dont say out loud display ads should work better than they do Budgets go in Impressions look fine CTRs are acceptable And yet pipeline barely moves

TOP ARTICLES

  • 4

    Chiral Biosensors: Precision Tools for Safer Drugs

    Dr. Selvakumar Kanthiah

    Dr. Valliappan Kannappan

    In drug development, identifying the right mirror-image molecule - called an enantiomer - can be the difference between a life-saving treatment and unwanted side effects. Chiral biosensors are revolut...

press releases Read more...

Medicovestor Announces FDA Fast Track Designation for MC001, Its First-in-Class Chemoimmunotherapy ADC for Pancreatic Cancer

Medicovestor Inc today announced that the US Food and Drug Administration FDA has granted Fast Track designation to MC its lead investigational firstinclass chemoimmunotherapy antibodydrugconjugate ADC for pancreatic cancer

Orogen Therapeutics Announces Selection of Two Development Candidates for Immune Diseases, Potential Best-in-Class Oral IL-17 and JAK1/TYK2 Small Molecule Inhibitors

Orogen Therapeutics Inc announced the selection of two development candidates DCs ORO and ORO potential bestinclass oral small molecule inhibitors of IL and JAKTYK respectively Both DCs have completed extensive nonclinical studies to demonstrate attractive

MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors

MacroGenics Inc a clinicalstage biopharmaceutical company focused on developing innovative antibodybased therapeutics for the treatment of cancer today announced that the first patient has been dosed in the Phase study of MGC a firstinclass antibodydrug conjugate

Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy

Legend Biotech Corporation a global leader in cell therapy today announced that the US Food and Drug Administration FDA has cleared the investigational new drug IND application for LB an investigational in vivo CART therapy designed to generate CDCD dualtargeting chimeric antigen receptor T

21 - 23

Oct 2026

21 - 22

Oct 2026

22 - 23

Oct 2026

PDA Aseptic Symposium 2026

Congress Square Nakanoshima, O...

26 - 28

Oct 2026

ACHEMA Middle East 2026

RICEC, Riyadh, KSA, Saudi Arab...

26 - 28

Oct 2026

World Orphan Drug Congress

RAI, Amsterdam, Netherlands

27 - 28

Oct 2026

Pharma Manufacturing & Automation Convention 2026

Novotel Hyderabad Airport, Ind...

28 - 30

Oct 2026

02 - 04

Nov 2026

Pharma Forum EMEA 2026

Dom Pedro Lisboa Hotel, Lisbon...

LATEST NEWS Read more...

ScionxBio Announces Collaboration to Develop Long-Acting xRNA Therapeutics

ScionxBio a privately held preclinicalstage biotechnology company pioneering nextgeneration mRNA therapeutics distinguished by their extended durability profile today announced that it has entered into a worldwide strategic collaboration and licensing agreement with Sanofi

Takara Bio USA Partners with SPT Labtech to Deliver Automation-Ready NGS Library Preparation Technologies

Takara Bio USA Inc a wholly owned subsidiary of Takara Bio Inc and SPT Labtech today announced their partnership to deliver validated automated library preparation workflows that combine Takara Bio nextgeneration sequencing NGS library preparation chemistries with SPT Labtechs firefly liquid handlin...

AtomVie Global Radiopharma Announces Strategic Partnership with Jubilant Radiopharma to Strengthen Logistics and Distribution in Clinical Trials

AtomVie Global Radiopharma a global contract developer and manufacturer CDMO for radiopharmaceuticals today announced a strategic partnership with Jubilant DraxImage Inc operating as Jubilant Radiopharma Jubilant Radiopharma to provide logistics approval and lastmile distribution services to support

Transcripta Bio Announces Research Collaboration to Advance Discovery of New ALS Treatments

Transcripta Bio an AIpowered drug discovery company focused on neurological and neuromuscular diseases today announced a research collaboration and licensing agreement with Mayo Clinic centered on amyotrophic lateral sclerosis ALS a fatal neurodegenerative disease with few effective treatments

Insitro Announces a Strategic Collaboration with AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies

Insitro an AI company unlocking causal human biology to systematically generate highvalue therapeutics to treat grievous illness today announced a worldwide exclusive research collaboration agreement with AstraZeneca to discover novel targets and therapeutics in metabolic dysfunctionassociated steat...

Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors

Vir Biotechnology Inc announced a collaboration and license agreement with Gilead to discover and engineer three novel PROXTEN dualmasked Tcell engager TCE development candidates targeting selected solid tumorassociated antigens Gilead will have an exclusive license to develop and commercialize